Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;92(4):418-424.
doi: 10.1134/S1019331622040086. Epub 2022 Sep 6.

Intensive Care of Patients with COVID-19

S S Petrikov  1 , K A Popugaev  1 , S V Zhuravel'  1
Affiliations

Intensive Care of Patients with COVID-19

S S Petrikov et al. Her Russ Acad Sci. 2022.

Abstract

The severe course of COVID-19 requires treatment in emergency and intensive care units. Acute respiratory failure due to the development of pneumonia and acute respiratory distress syndrome is the most common and life-threatening manifestation of the new coronavirus infection. Treatment of patients with severe and extremely severe COVID-19; the use of modern schemes and protocols for drug therapy, mechanical ventilation, and extracorporeal membrane oxygenation; sorption techniques; the use of thermal helium; hemostasis correction; and rehabilitation problems are discussed.

Keywords: coronavirus infection; extracorporeal membrane oxygenation; respiratory support; treatment protocols.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

    1. Chen G., Wu D., Guo W. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020;130:2620–2629. doi: 10.1172/JCI137244. - DOI - PMC - PubMed
    1. Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885–891. doi: 10.1038/nature01326. - DOI - PubMed
    1. Gao Y., Li T., Han M. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J. Med. Virol. 2020;92:791–796. doi: 10.1002/jmv.25770. - DOI - PMC - PubMed
    1. Tanaka T., Narazaki M., Kishimoto T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy. 2016;8:959–970. doi: 10.2217/imt-2016-0020. - DOI - PubMed
    1. Interim Guidelines: Prevention, Diagnosis, and Treatment of Novel Coronavirus Infection (COVID-19), Version 14 (Dec. 27, 2021) (Ministry of Health of the Russian Federation, 2021). https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/041...

LinkOut - more resources